newsfilter
← Latest News
GlobeNewswire·

Lipella Pharmaceuticals Marks Successful First Year with Strategic Progress and Key Milestones Accomplished

PITTSBURGH, Dec. 20, 2023 (GLOBE NEWSWIRE) -- Lipella Pharmaceuticals Inc., (NASDAQ:LIPO) ("Lipella," "our," "us" or the "Company"), a pioneering, clinical-stage pharmaceutical company,